Sherbrooke Park Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $297K | Sell |
566
-32
| -5% | -$16.8K | 0.13% | 309 |
|
|
2025
Q1 | $379K | Sell |
598
-1,406
| -70% | -$892K | 0.18% | 216 |
|
|
2024
Q4 | $1.43M | Buy |
+2,004
| New | +$1.43M | 0.46% | 14 |
|
|
2024
Q1 | – | Sell |
-714
| Closed | -$627K | – | 974 |
|
|
2023
Q4 | $627K | Buy |
714
+267
| +60% | +$235K | 0.29% | 120 |
|
|
2023
Q3 | $368K | Buy |
+447
| New | +$368K | 0.12% | 300 |
|
|
2023
Q1 | – | Sell |
-500
| Closed | -$361K | – | 299 |
|
|
2022
Q4 | $361K | Buy |
+500
| New | +$361K | 0.26% | 171 |
|